Menopausal hormone therapy and risk of epithelial ovarian cancer.
Rossing Mary Anne, Cushing-Haugen Kara L, Wicklund Kristine G, +2 more·Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Substantial increase in the use of menopausal hormone therapy (HT) throughout the 1990s, followed by widespread discontinuation after the 2002 publication of the Women's Health Initiative findings, has resulted in large numbers of former HT users among U.S. women. However, few studies have examined whether ovarian canc…